Depletion of Plasma Factor XIII Prevents Disseminated Intravascular Coagulation-induced Organ Damage

Summary The impact of clot stability affecting the vasculopathy and tissue necrosis in Shwartzman reaction was investigated using plasma Factor XIII A2-depleted rabbit (FXIII-DR). Plasma Factor XIIIA2 (FXIIIA2) was depleted by infusion of the mono-specific goat anti-rabbit FXIIIA2 IgG. Generalized Shwartzman reaction (GSR) was induced by priming and challenged by i.v. injection of LPS and local Shwartzman reaction (LSR) was primed by intradermal injection of LPS and challenged by i.v. injection of LPS. Histological examination of the GSR animals showed, extensive thrombi accumulation in renal tubules and bilateral cortical necrosis of kidney in 8 out of 10 rabbits but none in the FXIIIDR. Fibrinogen levels were elevated to 3~4 fold at 24 h and lowered at 48 h whereas a steady rise was seen in the FXIII-DR. FDP levels in GSR animals were significantly elevated at 24 h and further increased at 48 h but only slightly elevated in the FXIII-DR. Examination of the LSR tissues after 48 h showed an acute onset of progressive cutaneous vascular thrombosis, purpura, and secondary hemorrhagic necrosis whereas neither fibrin deposit nor necrosis of tissue were detected in FXIII-DR despite of an early edema formation. Fibrinogen levels were also increased two fold at 24 h but returned to basal levels at 48 h in control LSR animals but not affected at all in FXIII-DR. These results suggest that during the severe inflammatory conditions such as sepsis, the fibrinolytic system is functionally sufficient to dissipate the pathogenic accumulation of disseminated intravascular clots and exudated fibrin clots if those clots were prevented from getting cross-linked in plasma.

[1]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[2]  M. Caligiuri,et al.  Cutting Edge: IL-15 Costimulates the Generalized Shwartzman Reaction and Innate Immune IFN-γ Production In Vivo1 , 2000, The Journal of Immunology.

[3]  C. Vinson,et al.  Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. , 1999, Blood.

[4]  M. Levi,et al.  The Pathophysiology of Disseminated Intravascular Coagulation , 1999, Thrombosis and Haemostasis.

[5]  N. Koide,et al.  Expression of Fas and Fas Ligand on Mouse Renal Tubular Epithelial Cells in the Generalized Shwartzman Reaction and Its Relationship to Apoptosis , 1999, Infection and Immunity.

[6]  G. Darmstadt Acute Infectious Purpura Fulminans: Pathogenesis and Medical Management , 1998, Pediatric dermatology.

[7]  G. Senaldi,et al.  Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumour necrosis factor-mediated systemic inflammatory responses. , 1998, Cytokine.

[8]  S. I. Chung,et al.  Factors That Control Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.

[9]  T. van der Poll,et al.  Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. , 1995, Clinical science.

[10]  S. I. Chung,et al.  Regulation of extravascular fibrinolysis by factor XIII , 1991 .

[11]  H. Saito,et al.  FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. , 1991, Blood.

[12]  M. Cardinali,et al.  Interaction of fibrinogen with murine melanoma cells: covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells. , 1990, Cancer research.

[13]  J. Parrillo,et al.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.

[14]  S. Karpatkin,et al.  Crossed immunoelectrophoresis of human platelet membranes. Effect of charge on association and dissociation of the glycoprotein GPIIb-GPIIIa membrane complex. , 1986, The Journal of biological chemistry.

[15]  D. Crutchley,et al.  Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. , 1986, The Journal of biological chemistry.

[16]  J. Paramo,et al.  Postoperative Changes in the Plasmatic Levels of Tissue-Type Plasminogen Activator and Its Fast-Acting Inhibitor - Relationship to Deep Vein Thrombosis and Influence of Prophylaxis , 1985, Thrombosis and Haemostasis.

[17]  A. Siegelaub,et al.  The leukocyte count as a predictor of myocardial infarction. , 1974, The New England journal of medicine.

[18]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[19]  F. Duckert DOCUMENTATION OF THE PLASMA FACTOR XIII DEFICIENCY IN MAN , 1972, Annals of the New York Academy of Sciences.

[20]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[21]  P. Lalezari,et al.  A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  B S Bull,et al.  Platelet counts with the Coulter counter. , 1965, American journal of clinical pathology.